Robot model
LIBERTY Endovascular Robotic System
- Manufacturer
- Microbot Medical
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Website
- ir.microbotmedical.com ↗
Verified profile
1
Sources on record
0
Tracked changes
Updated recently
Last verified change
Deploy Watch
Track LIBERTY Endovascular Robotic System on Deploy.
We notify you when a verified state change lands on the record, not when the company issues a claim.
Data & sources
- Press releases1
1 source backing this record.View all →
Safety record
No incidents on record for LIBERTY Endovascular Robotic System.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
- Who makes LIBERTY Endovascular Robotic System?
- LIBERTY Endovascular Robotic System is made by Microbot Medical, based in Hingham, MA, USA.
- Where is LIBERTY Endovascular Robotic System deployed?
- No verified deployments of LIBERTY Endovascular Robotic System are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- What is LIBERTY Endovascular Robotic System's maturity stage?
- LIBERTY Endovascular Robotic System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Is LIBERTY Endovascular Robotic System safe?
- LIBERTY Endovascular Robotic System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-07-02
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-02
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for LIBERTY Endovascular Robotic System.Recent coverage
LIBERTY Endovascular Robotic System in third-party press
In the press
Recent coverage mentioning LIBERTY Endovascular Robotic System from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /models/liberty-endovascular.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/cd51c658-641a-4d09-b0ac-57aaf6874f42
- Revision history: /models/liberty-endovascular/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
DEPLOY Intelligence Score
5.2/ 100
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Safety Record
Adoption Spread
Market Presence
IP Activity
Deployment Scale
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
Last computed: Jul 3, 2026
Intelligence layer